Shares of the aviation services company declined in after-hours trading despite beating Q4 revenue and profit estimates, as investors focused on contracting operating margins and rising integration costs.
Shares of the clinical-stage biotech firm Dyne Therapeutics (NASDAQ:DYN) fell sharply after it revealed plans for a $300 million public stock offering to raise capital. The move is common for development-stage companies but often leads to share dilution for existing investors.
The property and casualty insurer reported a significant rise in second-quarter profit, driven by improved underwriting margins, lower catastrophe losses, and a double-digit increase in net investment income.
Bernstein has identified five top picks in the chemicals sector, favoring industrial gas companies like Linde and Air Products for their strong execution and margin potential.
Shares of Space Exploration Technologies Corp. (SPCX) rallied 4.4% on Tuesday, ending a seven-day decline after Macquarie reaffirmed its Outperform rating and the company set a new date for its next Starship test flight.
President Trump's nominee for Director of National Intelligence, Jay Clayton, has advanced to the full Senate after a narrow 9-8 vote in the Senate Intelligence Committee. The vote followed a contentious confirmation hearing where Clayton faced scrutiny over his stance on the 2020 election.
Shares of Astera Labs rose after the AI connectivity chipmaker announced its new 3.2T retimer and redriver solutions, a move complemented by a significant price target increase from Barclays.
Shares of the data center infrastructure provider gained after it announced a major expansion of its Italian manufacturing facility to meet surging demand for AI-related cooling systems.
The artificial intelligence leader has added David Vélez of Nubank and Robin Vince of BNY Mellon to its board, a move seen as strengthening governance before a widely expected public offering, according to The Wall Street Journal.
